Session » (1306–1346) Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II

Date: Monday, October 27, 2025

Time: 10:30AM-12:30PM

Meeting: ACR Convergence 2025

10:30AM-12:30PM: Abstract Number: 1331

Anti-beta-2-glycoprotein-1 IgA antibodies facilitate macrophage cholesterol loading and influence coronary atherosclerosis progression in a dose-dependent manner in rheumatoid arthritis

10:30AM-12:30PM: Abstract Number: 1333

Assessment of lipid abnormalities after initiation of a JAK inhibitor in rheumatoid arthritis in clinical practice

10:30AM-12:30PM: Abstract Number: 1326

Association Between Physical Function and Nutritional Status in Rheumatoid Arthritis Patients

10:30AM-12:30PM: Abstract Number: 1334

Cardiac Biomarkers and Prediction of Major Cardiovascular Events in Rheumatoid Arthritis: Results from the ESPOIR Cohort

10:30AM-12:30PM: Abstract Number: 1335

Chest x-Ray and pulmonary function tests are not sensitive for screening intertitial lung disease in reumatoid arthritis

10:30AM-12:30PM: Abstract Number: 1311

Decade-Based Trends in First Remission Among Rheumatoid Arthritis Patients: A Population-Based Study

10:30AM-12:30PM: Abstract Number: 1318

Diagnostic Delay in Rheumatoid Arthritis and its Impact on Radiographic Outcomes: A Systematic Review and Meta-analysis of 100,066 Patients

10:30AM-12:30PM: Abstract Number: 1340

Does Moderate Alcohol Use Lower Disease Activity Among Patients with Rheumatoid Arthritis?

10:30AM-12:30PM: Abstract Number: 1336

Effectiveness of new initiators of tofacitinib and other biologic/targeted synthetic DMARDs in patients with rheumatoid arthritis

10:30AM-12:30PM: Abstract Number: 1321

Efficacy and safety of janus kinase inhibitors in diffuse interstitial lung disease in rheumatoid arthritis. Systematic review

10:30AM-12:30PM: Abstract Number: 1323

Efficacy of Olokizumab in Treating Comorbid Depression in Patients with Rheumatoid Arthritis: Results of a Single-Center Randomized Controlled Trial

10:30AM-12:30PM: Abstract Number: 1312

Evolution of patients with active rheumatoid arthritis: analysis of disease activity trajectories in a tertiary‑care rheumatology department

10:30AM-12:30PM: Abstract Number: 1344

Exploring the Factors Associated with the Discontinuation of Tofacitinib in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study

10:30AM-12:30PM: Abstract Number: 1322

High Rheumatoid Factor Titers and Biologic Persistence in RA: Beyond TNF Inhibitors

10:30AM-12:30PM: Abstract Number: 1315

High-resolution thermography and Artificial Intelligence to evaluate and classify Rheumatoid Arthritis

10:30AM-12:30PM: Abstract Number: 1339

Inflammatory Rheumatic Diseases in IDH-mutated Myeloid Neoplasms: Clinical Spectrum and Response to IDH Inhibitors

10:30AM-12:30PM: Abstract Number: 1332

Mid‐Infrared Spectroscopy for Enhanced Diagnosis of Rheumatic Diseases

10:30AM-12:30PM: Abstract Number: 1328

Mortality Trends of Hypertension in Patients with Rheumatoid Arthritis in the United States (1999–2020)

10:30AM-12:30PM: Abstract Number: 1310

Naturalized Language Processing Based Extraction of Rheumatoid Arthritis Disease Activity Measures from the Electronic Health Record

10:30AM-12:30PM: Abstract Number: 1341

Physical Function Across Age in Patients With Rheumatoid Arthritis and Population Controls: A Cross-Sectional Study of Four Performance Measures

10:30AM-12:30PM: Abstract Number: 1307

Plasma levels of monounsaturated fatty acids (MUFAs) positively correlate with disease activity in patients with rheumatoid arthritis (RA)

10:30AM-12:30PM: Abstract Number: 1325

Plasma Matrix Metalloproteinases and Heart Failure Outcomes in Rheumatoid Arthritis

10:30AM-12:30PM: Abstract Number: 1316

Predicting mortality of rheumatoid arthritis in China: A nation-wide cohort study

10:30AM-12:30PM: Abstract Number: 1308

Predictors of Interstitial Lung Disease Progression in Patients with Rheumatoid Arthritis

10:30AM-12:30PM: Abstract Number: 1346

Preliminary Result of Investigating the Response of Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) Associated SNPs: One Cohort Study

10:30AM-12:30PM: Abstract Number: 1314

Protein-Specific Anti-Malondialdehyde-Acetaldehyde Antibodies and Cardiovascular Disease Outcomes in Rheumatoid Arthritis

10:30AM-12:30PM: Abstract Number: 1329

Relationship Between Circulating Bacterial Small RNAs, Methotrexate Response, and Microbiome in New Onset Rheumatoid Arthritis

10:30AM-12:30PM: Abstract Number: 1313

Retrospective Analysis of Factors Associated With Fracture in 2855 Patients With Rheumatoid Arthritis, Stratified by Steroid Use

10:30AM-12:30PM: Abstract Number: 1330

Sex and reproductive stage modify the role of endogenous estrogens on coronary atherosclerosis in rheumatoid arthritis and differences reflect effects on inflammation and cholesterol metabolism

10:30AM-12:30PM: Abstract Number: 1338

Short-Chain Fatty Acids and Their Gut Microbial Metabolic Pathways Distinguish Rheumatoid Arthritis in Discordant Monozygotic Twins

10:30AM-12:30PM: Abstract Number: 1324

Similar Negative Effects of Fatigue on Physical Activity in Persons with Rheumatoid Arthritis and Healthy Controls: A Patient-Control Study

10:30AM-12:30PM: Abstract Number: 1343

Six-Minute Walk Distance as a Functional Measure in Rheumatoid Arthritis-associated Interstitial Lung Disease Reflecting Both Lung and Joint Involvement

10:30AM-12:30PM: Abstract Number: 1306

Systematic Literature Review of Digital Sleep Outcomes and Endpoints Used to Assess Rheumatoid Arthritis

10:30AM-12:30PM: Abstract Number: 1327

Systematic Review of Mobility in Rheumatoid Arthritis with Digitally Measured Objective Assessment

10:30AM-12:30PM: Abstract Number: 1337

The Association Between Glucagon-Like Peptide-1 Receptor Agonist and Rheumatoid Arthritis: A Population-Based Case Control Study

10:30AM-12:30PM: Abstract Number: 1317

The Association Between Insomnia and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis of 546,822 Patients

10:30AM-12:30PM: Abstract Number: 1319

The Association of Rheumatoid Arthritis in Patients with Vitiligo: Systematic Review and Meta-Analysis

10:30AM-12:30PM: Abstract Number: 1342

The Impact of Age on Health-Related Quality of Life in Patients With Rheumatoid Arthritis Compared to Population Controls: A Cross-Sectional Analysis

10:30AM-12:30PM: Abstract Number: 1309

Transcriptomic biomarkers of progression from undifferentiated arthritis to rheumatoid arthritis

10:30AM-12:30PM: Abstract Number: 1320

Trends In Incidence and Risk factors For Incident Venous Thromboembolism in Patients with Rheumatoid Arthritis: A Population-Based Retrospective Cohort Study

10:30AM-12:30PM: Abstract Number: 1345

Upregulated TLR Signaling Identified in Difficult-to-Treat RA: A Propensity Score–Matched Transcriptome Study

« View all sessions from this meeting